Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AFJK
AFJK logo

AFJK Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
42.000
Open
41.520
VWAP
41.84
Vol
2.25K
Mkt Cap
132.99M
Low
41.520
Amount
94.01K
EV/EBITDA(TTM)
--
Total Shares
3.17M
EV
133.49M
EV/OCF(TTM)
--
P/S(TTM)
--
Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues.
Show More

Events Timeline

(ET)
2026-05-20
16:50:00
Aimei Health Technology Receives Nasdaq Compliance Notice
select
2026-05-05 (ET)
2026-05-05
11:30:00
Aimei Health Technology Co Ltd Trading Halted Due to Volatility
select
2026-04-28 (ET)
2026-04-28
09:50:00
Aimei Health Technology Trading Halted Due to Volatility
select
2026-04-22 (ET)
2026-04-22
10:00:00
Aimei Health Technology Co Ltd Trading Halted
select
2026-04-15 (ET)
2026-04-15
10:00:00
Aimei Health Technology Co Ltd Trading Halted Due to Volatility
select

News

seekingalpha
7.0
05-20seekingalpha
Aimei Health Technology Fails to File Quarterly Report on Time
  • Compliance Notice: Aimei Health Technology received a notice from Nasdaq on Wednesday for failing to comply with listing rules due to a delay in filing its quarterly report for the period ended March 31, which was due on May 15, indicating potential issues in the company's financial transparency.
  • Listing Impact: Despite the notice, Aimei stated that it has no immediate effect on its listing or trading of securities on Nasdaq, suggesting that the company can maintain its market position in the short term.
  • Compliance Plan Timeline: Under Nasdaq rules, the company has 60 calendar days to file the report or submit a compliance plan, providing a buffer period to address compliance issues and avoid more severe consequences.
  • Potential Consequences: If the compliance plan is accepted, Nasdaq may grant the company up to 180 days to regain compliance, offering flexibility for the company to improve its financial reporting processes and maintain investor confidence.
Benzinga
2.0
01-22Benzinga
WhiteFiber Inc (WYFI) Announces $200 Million Convertible Notes Offering, Shares Drop 5.5%
  • Convertible Notes Offering: WhiteFiber Inc announced a $200 million convertible notes offering, resulting in a 5.5% drop in its share price during pre-market trading, which may negatively impact investor confidence and future financing capabilities.
  • Market Reaction: Following the convertible notes announcement, WhiteFiber's stock fell to $19.19 in pre-market trading, reflecting market concerns over the company's financial health and potentially affecting shareholder returns.
  • Other Stock Movements: Caleres, Inc. shares tumbled 8.6% in pre-market trading after naming Dan Karpel as interim CFO, indicating that changes in corporate governance may impact its market performance.
  • Overall Industry Trends: Aura Biosciences Inc shares dipped 7%, while GoldMining Inc and T1 Energy Inc fell 5.5% and 5.4% respectively, suggesting a general downturn in market sentiment that could affect investor confidence across related sectors.
Benzinga
2.0
01-05Benzinga
mF International Files Mixed Shelf, Shares Drop 4.6%
  • Stock Decline: mF International's shares fell 4.6% to $17.61 in pre-market trading, reflecting market concerns over its mixed shelf filing, which may impact investor confidence and liquidity.
  • Market Reaction: SBC Medical Group's stock plummeted 18.9% to $3.51 in pre-market trading, indicating negative sentiment in the healthcare sector that could affect the company's future financing capabilities.
  • Other Stock Movements: Aimei Health Technology's shares declined 7.7% to $70.00, suggesting cautious market sentiment regarding its outlook, which may impact its market share and investor appeal.
  • Executive Change: NetEase announced the retirement of Yingfeng Ding, EVP of the Interactive Entertainment Group, which could lead to strategic shifts affecting the future performance of its online gaming division.
Benzinga
8.5
01-02Benzinga
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
  • Capital Raising Announcement: Intelligent Bio Solutions revealed plans to raise $10 million through a private placement, which led to a sharp 19.7% decline in its stock price during Friday's session, indicating a negative impact on investor confidence and market performance.
  • Stock Price Reaction: Following the announcement, shares of Intelligent Bio fell to $7.65, reflecting market concerns regarding the company's future financial health and potentially affecting its ability to secure further funding.
  • Market Dynamics: While Intelligent Bio's stock plummeted, other stocks such as Lavoro Limited and Ironwood Pharmaceuticals surged by 181% and 57.7% respectively, highlighting a divergence in market performance among different companies.
  • Investor Focus: The announcement of this capital raising plan may prompt investors to reassess Intelligent Bio's strategic direction, particularly in the current market environment where the necessity and timing of fundraising are critically important.
Benzinga
7.0
01-02Benzinga
Ironwood Pharmaceuticals Issues FY26 Guidance, Shares Surge 57.7%
  • Sales Guidance Boost: Ironwood Pharmaceuticals anticipates 2026 US net sales for Linzess to reach between $1.125 billion and $1.175 billion, indicating strong market demand that is expected to drive future revenue growth.
  • Revenue Expectations Rise: The company projects total revenue for 2026 to be between $450 million and $475 million, which is likely to enhance investor confidence and attract more capital inflow.
  • Strong EBITDA Forecast: Ironwood expects adjusted EBITDA to exceed $300 million in 2026, indicating ongoing improvements in profitability that could elevate its market valuation.
  • Significant Stock Surge: Following the announcement, Ironwood's shares surged 57.7% to $5.32, reflecting a positive market reaction to its growth potential.
Benzinga
4.5
01-02Benzinga
Baidu Inc Proposes Spinoff of Kunlunxin H Shares, Stock Rises 12.3%
  • Stock Surge: Baidu's announcement of a proposed spinoff of Kunlunxin (Beijing) Technology Co., Ltd. H shares for a separate listing on the Hong Kong Stock Exchange led to a 12.3% increase in its stock price to $146.69 in pre-market trading, indicating strong market enthusiasm for this strategic move.
  • Spinoff Strategy: The spinoff aims to enhance Kunlunxin's independence and market valuation, which is expected to provide Baidu with more flexible capital operations and resource allocation, thereby strengthening its competitive position in the technology sector.
  • Market Reaction: The spinoff news has sparked investor excitement, with the significant rise in Baidu's stock reflecting confidence in its future growth potential and likely attracting more institutional investors to its shares.
  • Industry Impact: By pursuing this spinoff, Baidu can focus more on its core business while providing Kunlunxin with greater development space, which is anticipated to drive innovation and investment activity across the technology industry.

Valuation Metrics

The current forward P/E ratio for Aimei Health Technology Co Ltd (AFJK.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Aimei Health Technology Co Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.11
Current PS
0.00
Overvalued PS
1.24
Undervalued PS
-1.01

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

list10 stocks up 5%
Intellectia · 371 candidates
Price Change Pct: >= $5.00
Ticker
Name
Market Cap$
top bottom
AGPU logo
AGPU
Axe Compute Inc
25.59M
ELPW logo
ELPW
eLong Power Holding Ltd
2.23M
TORO logo
TORO
Toro Corp
112.81M
NMAX logo
NMAX
Newsmax Inc
940.13M
BEEM logo
BEEM
Beam Global
32.13M
XNDU logo
XNDU
Xanadu Quantum Technologies Ltd
8.18B
for crypto?
Intellectia · 1112 candidates
Rsi Category: moderate, overboughtMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Week Price Change Pct: >= $5.00Macd: positive, bullish
Ticker
Name
Market Cap$
top bottom
UCAR logo
UCAR
U Power Ltd
4.97M
BBGI logo
BBGI
Beasley Broadcast Group Inc
21.24M
CUE logo
CUE
Cue Biopharma Inc
49.02M
MGRT logo
MGRT
Mega Fortune Co Ltd
677.88M
SKYQ logo
SKYQ
Sky Quarry Inc
47.31M
ZNTL logo
ZNTL
Zentalis Pharmaceuticals Inc
468.85M

Whales Holding AFJK

W
W. R. Berkley Corporation
Holding
AFJK
+6.86%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Aimei Health Technology Co Ltd (AFJK) stock price today?

The current price of AFJK is 42 USD — it has increased 1.16

What is Aimei Health Technology Co Ltd (AFJK)'s business?

Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues.

What is the price predicton of AFJK Stock?

Wall Street analysts forecast AFJK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFJK is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aimei Health Technology Co Ltd (AFJK)'s revenue for the last quarter?

Aimei Health Technology Co Ltd revenue for the last quarter amounts to -250.59K USD, decreased -37.67

What is Aimei Health Technology Co Ltd (AFJK)'s earnings per share (EPS) for the last quarter?

Aimei Health Technology Co Ltd. EPS for the last quarter amounts to -43232.00 USD, decreased -77.84

How many employees does Aimei Health Technology Co Ltd (AFJK). have?

Aimei Health Technology Co Ltd (AFJK) has 0 emplpoyees as of May 30 2026.

What is Aimei Health Technology Co Ltd (AFJK) market cap?

Today AFJK has the market capitalization of 132.99M USD.